DERM LIGHT

GOAL

Evaluation of the efficacy of PBM in the management of hand-foot syndrome and hand-foot skin reaction in patients with cancer. 

STUDY DESIGN

 Prospective, interventional, single-group, open-label study at Jessa Hospital from January 2022 until present (NCT04979078).

PBM group

PBM (3x/week, 3 weeks) + standard skin care

STUDY RESULTS

No preliminary results are available. 

PUBLICATIONS

 

PARTNERS